Genomics is the study of the entire human genome. Genomics explores not only the actions of single genes, but also the interactions of multiple genes with each other and with the environment. As a result, genomics has great potential for improving the health of the public. However, realizing the ben
Systems for Research and Evaluation for Translating Genome-Based Discoveries for Health: Workshop Summary
โ Scribed by Roundtable on Translating Genomic-Based Research for Health, Institute of Medicine
- Year
- 2009
- Tongue
- English
- Leaves
- 103
- Category
- Library
No coin nor oath required. For personal study only.
โฆ Synopsis
With the advent of genome-wide association studies, numerous associations between specific gene loci and complex diseases have been identified--for breast cancer, coronary artery disease, and asthma, for example. This rapidly advancing field of genomics has stirred great interest in "personalized" health care from both the public and private sectors. The hope is that using genomic information in clinical care will lead to reduced health care costs and improved health outcomes as therapies are tailored to the genetic susceptibilities of patients. A variety of genetically based health care innovations have already reached the marketplace, but information about the clinical use of these treatments and diagnostics is limited. Currently data do not provide information about how a genomic test impacts clinical care and patient health outcomes--other approaches are needed to garner such information. This volume summarizes a workshop to address central questions related to the development of systems to evaluate clinical use of health care innovations that stem from genome-based research: What are the practical realities of creating such systems? What different models could be used? What are the strengths and weaknesses of each model? How effectively can such systems address questions about health outcomes?
โฆ Table of Contents
FrontMatter......Page 2
Reviewers......Page 10
Acknowledgments......Page 12
Contents......Page 14
1 Introduction......Page 18
2 Generating Evidence for Decision Making......Page 20
3 Creating Evidence Systems......Page 30
4 Current Practices in Moving from Evidence to Decision......Page 50
5 Panel: Where Are the Gaps?......Page 70
6 Closing Remarks......Page 82
References......Page 86
Appendix A: Workshop Agenda......Page 90
Appendix B: Speaker Biosketches......Page 94
๐ SIMILAR VOLUMES
This book will provide a detailed history and discussion of the use of human tissues as an alternative to animal-based testing for assessing the efficacy and safety of new medicines. Beginning by providing the history and background of animal-based testing, this text then describes in detail the iss
<p>The number of new drug approvals has remained reasonably steady for the past 50 years at around 20 to 30 per year, while at the same time the total spending on health-related research and development has tripled since 1990. There are many suspected causes for this trend, including increases in re
Rapid advances in technology have lowered the cost of sequencing an individual's genome from the several billion dollars that it cost a decade ago to just a few thousand dollars today and have correspondingly greatly expanded the use of genomic information in medicine. Because of the lack of evidenc
Major depressive disorder (MDD) is recognized worldwide as a major cause of disability, morbidity, and mortality. According to the World Health Organization, unipolar depressive disorders affect more than 150 million people around the world and represent the leading cause of years lost due to disabi